Abstract-Using pharmacological approaches, we obtained evidence for the release of dopamine (DA) and its dopaminergic regulation in the guinea pig spinal cord. Electrical stimulation of the cord pieces increased the endogenous DA release and the efflux of Several studies have suggested the pos sibility that dopamine (DA) in the spinal cord is not only a precursor of norepinephrine but can also act as an independent neurotrans mitter in the separate DA neuron system (1, 2). The dopaminergic pathways were con sidered to descend from the nigral (A9) (1, 3), diencephalic (A11) (4-6) and hypo thalamic (Al 3) (7) cell groups to the spinal cord. Recently, the descending spinal DA system has been shown to originate primarily in the diencephalic Al 1 cell group, forming a diencephal-spinal DA pathway (8). We obtained autoradiographical evidence for the localization of dopaminergic terminals in the spinal cord (9). However, the criteria for a neurotransmitter in case of the spinal cord has not been fully satisfied. In particular, there has been no evidence of a stimulus dependent release of DA from the cord. The presynaptic dopamine receptors ap pear to modulate the rate of DA biosynthesis and impulse-induced DA release by a local negative feedback mechanism in the nigro striatal (10, 11) and mesolimbic systems (10 12), while the mesocortical (13) and tuberoinfundibular DA systems (11) appear to lack DA autoreceptor. There is, however, no information concerning autoreceptors in the spinal DA system. Here, we report the first data obtained about the release of DA from the spinal cord and its presynaptic regulation via the DA receptor.
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Materials and Methods
Guinea pigs of both sexes, weighing 350 450 g, were decapitated, and tracheotomy was performed to identify the segments. The segments Ct-C5 were quickly removed by a complete laminectomy and divided into left and right halves by the cutting at the posterior median sulcus. Using small scissors under a dissecting microscope, the dorsal half of the gray matter was carefully removed from the white matter. Endogenous DA release: The tissue pre parations (approximately 55 mg each) were set in the superfusion chamber. The tissue was then superfused at a constant rate of 0.2 ml/min with Krebs-Ringer bicarbonate solution oxygenated with 95% 02 and 5% CO2 and maintained at 37'C. Krebs-Ringer bicarbonate solution had the following com position (mM): NaCI, 118; KCI, 3; MgC12, 1.2; NaH2PO4, 1.2; NaHCO3, 23; glucose, 11 ; pargyline, 0.1; and ascorbic acid, 0.5.
The superfusate was continuously collected into a test tube containing 0.1 ml of 0.4 M HCIO4 and sodium metabisulphite (2 mg) every 5 min. Each superfusate was gathered respectively from 4 cord pieces of two animals. The superfusate was adjusted to pH 8.3 with 2 M Tris-HCI buffer, pH 8.3, and 0.5 M NaOH solution. Endogenous DA in the superfusate was absorbed with 5 mg of activated aluminum oxide and eluted with 20 jil of 0.1 M HCI. DA in the eluates was determined using HPLC (Hitachi 655 liquid  chromatograph) with an electrochemical detector (IRCA E-502) as described in our previous reports (14, 15) .
[3H] DA release: The preliminary uptake experiment was performed to determine the best conditions for the [3H] DA loading to the tissues. The dorsal half of the gray matter (approximately 5 mg each) was preincubated for 10 min at 37'C in 2 ml of Krebs-Ringer bicarbonate solution containing benztropine, DMI or ouabain equilibrated with 95% 02 and 5% CO2 and then incubated with [3H] DA (10-7M) for 15 min at 37°C in the same medium. After incubation, the tissues were rinsed in 10 ml of fresh medium 3 times every 10 min and then dissolved by sonication in 0.5 ml of sodium laurylsulfate (10%). The radioactivity in the tissue was measured in a liquid scintillation spectrometer.
In the release experiments, the spinal cord pieces (approximately 5 mg) were loaded with the medium containing [3H] DA (10-7 M) and DMI (5X10-6 M) for 45 min at 37°C. After rinsing with fresh medium, the pre paration was mounted in the superfusion chamber, then superfused with the medium as described above. The superfusion chamber was saturated with 95% 02 and 5% CO2 throughout the experiment. The period of equilibration before the start of the experiment was 30 min. The superfusate was con tinuously collected every 5 min, and the radioactivity determined in a liquid scin tillation spectrometer. The unchanged [3H] DA in the superfusate was estimated using H PLC (14, 15). A half-volume (0.5 ml) of the samples was used to separate unchanged [3H] DA, and the remaining parts of the samples were prepared for estimation of the total radioactivity. To the sample was added 10 ng of labeled DA as the carrier, and DA in the samples was extracted by the alumina absorption method and identified by H PLC, as described above. The fractions containing DA were collected from the outflow of H PLC, and radioactivity in these fractions was determined by liquid scintillation spectro meter. The amounts of unchanged [3H] DA in the sample obtained before and during the stimulation period were 75±4.85 and 76±7% of the total radioactivity, respectively. Ac cordingly, the total radioactivity in the superfusate was considered to represent the approximate amount of [3H] DA and, there fore, will further be denoted as [3H] DA release.
Electrical stimulation: The preparation was impaled with a pair of parallel platinum electrodes (0.1 mm in diameter; distance, 1.5 mm). Stimulation composed of mono phasic pulses (1 msec duration) were applied for 2 min at various intensities of current (0.5 3.0 mA) and different frequencies (1-20 Hz).
Drug and chemicals: The following drugs were gifts: LY-171555 (Eli Lilly), (-) sulpiride (Fujisawa), (Smith Kline), benztropine (Merck). The following drugs were from commercial sources: [3H] dopamine (45.4 Ci/mmol, New England Nuclear), dopamine HCI and pargyline HCI (Nakarai), desmetylimipramine (Fujisawa), tetrodotoxin (Sankyo), ouabain (Takeda) and 8-Br-cAMP (Sigma). All other chemicals were of reagent grade.
Statistical analyses: Data were analyzed by Student's t-test, and differences were accepted as significant at the 0.05 level of probability. The spontaneous tritium efflux assumed a fairly constant level in each experiment after 60 min superfusion. The fractional rate constant was about 0.002 per minute. Electrical stimulation produced an increase in the tritium efflux above the level before stimulation. The stimulated [3H] DA release is dependent on the applied current (0.5 3.0 mA) or frequency (1-20 Hz) (Fig. 1) . The [3H] DA release induced by stimulation of a current less than 1.5 mA was completely suppressed by TTX (10-6 M) or Ca2+ deprivation, indicating the requirement of a rapid Na+ influx and the Ca2+ influx (Fig. 1A) . Significant increases in the spontaneous and stimulated [3H] DA release were produced by adding 10-5 M benztropine to the super fusion medium ( Fig. 2A) , by which recapture of the released [3H] DA from the dopaminergic nerve terminals seems to be prevented. In the tissues preloaded with [3H] DA in the medium containing both benztropine and DMI, the electrical stimulation did not produce any alteration in [3H] DA release (Fig. 2B) .
Presynaptic dopaminergic regulation of DA release: When the spinal cord pieces were superfused with the medium containing 10-5 M LY-171555, a D2 receptor agonist, (16) the stimulated [3H] DA release was markedly suppressed without any changes in the spontaneous release. The stimulated [3H] DA release was reduced to 63% of control values by 10-6M LY-171555. Whereas, SKF-38393 (10-5 M, a Di agonist) and 8-Br-cAMP (3 x10-3 M) did not affect the evoked [3H] DA release (Table 2) , (-)sulpiride (10-6 M) enhanced the stimulated [3H]DA release to 150% of the control. Inhibition of stimulated [3H] DA release induced by LY-171555 (10-6 M) was also reversed by 10-6 M (-)sulpiride, but not by 10-5 M SKF-38393 or 3x10-3 M 8-Br-cAMP. When the preparation was superfused with the medium containing 10-6 M (-)sulpiride, endogenous DA release induced by electrical stimulation (1.5 mA, 10 Hz, 1 msec) for 2 min was increased to 154% of control values (Table 1) . From these findings, DA release in the spinal cord seems to be regulated via dopamine receptors. 
Discussion
The present results revealed that endoge nous DA can be released from tissue stores in the isolated guinea pig spinal cord in response to electrical stimulation. Since the DA contents in the spinal cord is lower than in the dopaminergic brain area, it was difficult to detect endogenous DA released from the cord into the superfusion medium. In the present study, the electrically stimulated DA release was measured using HPLC with a sensitive electrochemical detector. Electrical stimulation (1.5 mA, 10 Hz, 1 msec) for 2 min produced a release of endogenous DA of approximate 242 pg/g/5 min, which was 4-fold spontaneous DA efflux. The properties of the stimulated DA release were analyzed using labeled DA. Labeled DA is known to be taken up by nerve terminals other than dopaminergic terminals such as noradrenergic and serotonergic terminals (17, 18). The By analogy with the situation of ACh (27) and glutamate (29) release from the striatum, the D2 receptor mediated inhibition of DA release was not quite affected by the D, agonist and 8-Br-cAMP, suggesting that the D2 receptor mediating inhibition in the spinal DA release is independent of the inhibition of cAMP generation.
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